Have a personal or library account? Click to login
The Impact of Hyperoxia Treatment on Neurological Outcomes and Mortality in Moderate to Severe Traumatic Brain Injured patients Cover

The Impact of Hyperoxia Treatment on Neurological Outcomes and Mortality in Moderate to Severe Traumatic Brain Injured patients

Open Access
|Aug 2021

Figures & Tables

Fig. 1

Adjusted odd ratio for hospital mortality (A) and Glasgow outcome score ≥4 (B) for persistent hyperoxia and different PaO2 ranges.

Hospital outcomes for cohort_

VariablesAll N=309Group I N=169Group II N=140p-value
ICU Length of stay (days), mean(SD)15.9(18.7)17.1923.2)14.5(11.2)0.23
Hospital length of stay (days), mean(SD)54.3(76.2)60.2(86.5)47.2(61.3)0.13
Duration on MV (days), mean(SD)10.1(8.4)10.6(6.3)9.5(10.3)0.25
Tracheostomy, N (%)80 (25.9)51 (34.2)29 (23.8)0.06
ICU mortality, N (%)59 (19.1)34 (20.1)25 (17.9)0.62
Hospital mortality, N (%)60 (19.4)35 (20.7)25 (17.9)0.53
ICU discharge GCS, mean(SD)9.2(4.7)8.9(4.8)9.5(4.7)0.33
Hospital discharge GCS, mean(SD)11.1(5.0)11.0(5.1)11.2(4.9)0.70
Hospital discharge GOS, mean(SD)3.1(1.2)3.1(1.3)3.1(1.2)0.47
Hospital discharge GOS <4206 (66.7)113 (66.9)93 (66.4)0.92
Hospital discharge GOS ≥4103 (33.3)56 (33.1)47 (33.6)0.94

Hospital outcomes in subgroup analysis_

VariablesHospital Mortality N (%)
Hospital discharge GOS, mean(SD)
Group IGroup IIP valueGroup IGroup IIP value
GCS <933 (23.9)24 (20.9)0.563.0(1.3)3.0(1.2)0.92
Isolated TBI11 (22.4)9 (19.1)0.692.8(1.2)3.2(1.3)0.94
HIP22 (24.7)16 (21.1)0.583.0(1.3)3.1(1.2)0.61
PF ratio <30027 923.1)15 (29.4)0.383.0(1.3)2.8(1.3)0.31
PF ratio>3008 (15.4)10 (11.2)0.483.3(1.1)3.4(1.0)0.58
SAH20 (29.9)14 (29.2)0.942.7(1.3)2.8(1.1)0.87
SDH21 (30.4)15 (26.8)0.652.7(1.3)2.9(1.3)0.42

Baseline Characteristics

VariablesAll N=309Group I N=169Group II N=140p-value
Age (years), mean(SD)31.4(12.4)32.2(13.0)30.6(11.6)0.28
Male gender, N (%)293 (94.8)164 (97.0)129 (92.1)0.53
Body Mass Index 9kg/m2), mean(SD)23.7(5.3)24.5(5.6022.8(4.7)0.07
Ideal Body Weight (kg), mean(SD)65.0(6.5)65.4(6.7)64.6(6.4).028

Source of admission, N (%)
Emergency Department260 (84.1)147(87.0)113 (80.7)0.13
Operating Room49 (15.9)22 (13.0)27 (19.3)

Markers of Injury Severity, mean(SD)
Injury Severity Score, points30.0(7.5)29.996.8)30.2(8.2)0.74
Revised Trauma Score, points5.3(1.1)5.3(1.2)5.4(1.1)0.63
Shock Index0.86(0.3)0.9(0.4)0.8(0.3)0.19
IMPACT mortality, %27.9(17.9)29.2(18.7)26.5(16.8)0.19
IMPACT outcome, %41.7(20.5)43.1(20.9)40.1(19.9)0.20

Physiological Parameters, mean(SD)
Systolic blood pressure, mmHg128.3(26.5)128.4(27.4)128.1(25.6)0.91
MAP, mmHg94.4(22.6)93.8(23.9)95.1(21.1)0.60
Heart rate, beats/min104.7(28.2)106.8(28.7)102.2(27.5)0.15
Respiratory rate, breaths/min24.3(7.0)24.7(7.2)23.8(6.7)0.31
Oxygen saturation, %95.7(8.7)95.0(10.3)96.5(6.3)0.12
Temperature, °C36.7(0.7)36.7(0.7)36.7(0.7)0.67
CVP, mmHg10.7(4.6)11.6(5.0)9.6(3.8)0.01
Arrival GCS5.9(2.8)5.9(2.9)5.9(2.7)0.88
GCS 9-12, N(%)55(17.8)31(18.3)25 17.9)0.53
GCS ≤ 8, N(%)253(81.9)138(81.7)115(82.1)

Laboratory Parameters, mean(SD)
White blood cell count, 109/L17.3(6.8)17.5(7.3)17.1(6.2)0.68
Hemoglobin, gm/L139.3(25.0)0.44(0.07)0.41(0.1)0.04
Platelets, 109/L271.9(90.7)274(90.5)270(91.3)0.70
Sodium, mmol/L139.6(4.1)139.6(4.2)139.7(4.0)0.81
Chloride, mmol/L108.2(8.6)108.5(6.2)107.8(10.8)0.49
Creatinine, umol/L90.1(61.2)94.3(78.7)85.0(27.9)0.18
Lactic Acid, mmol/L3.2(2.9)3.4(3.0)3.0(2.9)0.34
AST, U/L111.8(163.8)135.3(207.0)83.9(80.6)0.06
ALT, U/L81.6(134.1)100.4(169.6)59.3(66.0)0.07

Respiratory and Ventilator Parameters, mean(SD)
Tidal volume, mL425(37.9)427(42.7)422(30.8)0.24
Tidal volume per IDBW, mL/kg6.6(0.8)6.6(0.8)6.6(0.8)0.90
FiO2, %0.8(0.3)0.8(0.3)0.8(0.3)0.93
PEEP, mmHg5.9(3.2)6.1(3.8)5.7(2.1)0.31
pH7.29(0.9)7.29(0.1)7.29(0.1)0.44
PaCO2, mmHg4..2(9.3)43.8(9.9)42.5(8.5)0.23
PaO2, mmHg228.4(143.4)175.8(117.8)291.9(146.2)<0.001
PaO2/FiO2 ratio,316(237)240(171)407.5(272.5)<0.001

CT Head Findings, N(%)
Epidural Hematoma26(8.4)16(9.5)10(7.1)0.50
Subdural Hematoma125(40.5)69(40.8)56(40.0)0.88
Subarachnoid hemorrhage115(37.2)67(39.6)48(34.3 )0.33
Intraparenchymal Hemorrhage/Contusion151(48.9)81(47.9)70(50.0)0.72
Intraventricular Hemorrhage46(14.9)26(15.4)20(14.3)0.79
Cerebral Edema107(34.6)54(32.0)53(37.9)0.28
Midline Shift ≥5mm42(13.6)19(11.2)23(16.4)0.19
Axonal Injury20(6.5)11(6.5)9(6.4)0.98
Herniation30(9.7)15(8.9)15(10.7)0.59
Normal findings50(16.2)25(14.8)25(17.9)0.47
Isolated Head Injury, N (%)96(30.1)49(29.0)47(33.6)0.39

Management
Fluid balance at 24 hours (mL), mean±SD3372(2528)3435(2678)3298(2343)0.64

Blood products (Units), mean(SD)
Red blood cells2.1(3.9)1.8(3.8)2.3(3.9)0.26
Platelets6.2(4.9)7.5(5.8)5.1(3.6)0.05
Fresh frozen plasma5.8(4.6)6.4(5.1)5.3(3.6)0.27

Tranexamic acid, N(%) 50 (29.8)45 (32.4)0.62
Vasopressor index, mean(SD)3.5(0.7)3.5(0.7)3.5(0.6)0.46
ICP Monitoring, N(%)47(15.2)22(14.1)25(19.2)0.24
Hypertonic saline, N(%)155(50.2)87(59.6)68(57.1)0.69
Head injury protocol, N(%)165(53.4)89(86.5)76(70.4)0.75
DOI: https://doi.org/10.2478/jccm-2021-0014 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 227 - 236
Submitted on: Jan 3, 2021
|
Accepted on: May 3, 2021
|
Published on: Aug 5, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Raymond Khan, Sarah Alromaih, Hind Alshabanat, Nosaiba Alshanqiti, Almaha Aldhuwaihy, Sarah Abdullah Almohanna, Muna Alqasem, Hasan Al-Dorzi, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.